Morgan Stanley’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History
Bought
Maintained
Sold
Other funds holding BOUT
CWM
CMMS
MMCM
HCM
SS
Morgan Stanley's BOUT Position: Q1 2026 in Review
Morgan Stanley sold out of CapForce IBD Breakout Opportunities ETF (BOUT) in Q1 2026, closing a stake of 1 share — an estimated $47 sold.
Morgan Stanley first reported a position in BOUT in Q3 2019 and held it in 19 quarters. The position peaked at $77K in Q4 2021. 14 funds tracked by Wall St. Rank hold BOUT as of Q1 2026.
- Morgan Stanley reported no remaining CapForce IBD Breakout Opportunities ETF position as of Q1 2026 after selling out during the quarter.
- Morgan Stanley sold 1 CapForce IBD Breakout Opportunities ETF share in Q1 2026, an estimated $47.
- Morgan Stanley first reported a position in CapForce IBD Breakout Opportunities ETF in Q3 2019 and held it in 19 quarters.
- Morgan Stanley's CapForce IBD Breakout Opportunities ETF position peaked at $77K in Q4 2021.
- 14 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.